Items where authors include "Francis, R."

Article

Liew, F., Efstathiou, C. orcid.org/0000-0001-6125-8126, Fontanella, S. et al. (1457 more authors) (2024) Large-scale phenotyping of patients with long COVID post-hospitalization reveals mechanistic subtypes of disease. Nature Immunology, 25 (4). pp. 607-621. ISSN 1529-2908

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Lord, J.M., Veenith, T., Sullivan, J. et al. (1020 more authors) (2024) Accelarated immune ageing is associated with COVID-19 disease severity. Immunity & Ageing, 21. 6. ISSN 1742-4933

Lord, J.M., Veenith, T., Sullivan, J. et al. (1020 more authors) (2024) Accelarated immune ageing is associated with COVID-19 disease severity. Immunity & Ageing, 21. 6. ISSN 1742-4933

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Michael, B.D. orcid.org/0000-0002-8693-8926, Dunai, C. orcid.org/0000-0001-5799-2387, Needham, E.J. orcid.org/0000-0001-7042-7462 et al. (559 more authors) (2023) Para-infectious brain injury in COVID-19 persists at follow-up despite attenuated cytokine and autoantibody responses. Nature Communications, 14 (1). 8487. ISSN 2041-1723

Elneima, O. orcid.org/0000-0003-2480-8840, McAuley, H.J.C. orcid.org/0000-0001-8997-0764, Leavy, O.C. et al. (1398 more authors) (2023) Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology. ISSN 0300-5771

Brightling, C.E., Evans, R.A., Singapuri, A. et al. (1049 more authors) (2023) Long COVID research: an update from the PHOSP-COVID Scientific Summit. The Lancet Respiratory Medicine, 11 (11). e93-e94. ISSN 2213-2600

Raman, B., McCracken, C., Cassar, M.P. et al. (1038 more authors) (2023) Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. The Lancet Respiratory Medicine, 11 (11). pp. 1003-1019. ISSN 2213-2600

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Jackson, C., Stewart, I.D., Plekhanova, T. et al. (1082 more authors) (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Respiratory Medicine, 11 (8). pp. 673-684. ISSN 2213-2600

Zheng, B., Vivaldi, G. orcid.org/0000-0003-0816-9276, Daines, L. orcid.org/0000-0003-0564-4000 et al. (1040 more authors) (2023) Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. The Lancet Regional Health - Europe, 29. 100635. ISSN 2666-7762

Zheng, B., Vivaldi, G. orcid.org/0000-0003-0816-9276, Daines, L. orcid.org/0000-0003-0564-4000 et al. (1040 more authors) (2023) Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. The Lancet Regional Health - Europe, 29. 100635. ISSN 2666-7762

Jackson, C., Stewart, I.D., Plekhanova, T. et al. (1082 more authors) (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Respiratory Medicine. ISSN 2213-2600

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Liew, F. orcid.org/0000-0002-8736-9198, Talwar, S., Cross, A. et al. (1439 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine, 87. 104402. ISSN 2352-3964

Brown, J.E., Handforth, C., Compston, J.E. et al. (13 more authors) (2020) Guidance for the assessment and management of prostate cancer treatment-induced bone loss. A consensus position statement from an expert group. Journal of Bone Oncology, 25. 100311. ISSN 2212-1374

Akawi, N., McRae, J., Ansari, M. et al. (40 more authors) (2015) Discovery of four recessive developmental disorders using probabilistic genotype and phenotype matching among 4,125 families. Nature Genetics, 47 (11). pp. 1363-1369. ISSN 1061-4036

Porthouse, J., Cockayne, S., King, C. et al. (12 more authors) (2005) Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. British Medical Journal, 330 (7498). pp. 1003-1009. ISSN 0959-8138

Monograph

Dacre, J., Francis, R., Appleby, J. et al. (7 more authors) (2022) Expert panel : evaluation of the Government’s commitments in the area of cancer services in England. Report. House of Commons Health and Social Care Committee Reports (HC 1025). House of Commons , London.